https://doi.org/10.1016/j.euroneuro.2013.12.008
D
David A. Hosford
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
3.9K
Citations
27
h-index
36
i10-index
David A. Hosford is an academic researcher from Southeast Clinical Oncology Research Consortium. The author has contributed to research in topics: Neuroscience and Neuropharmacology Research & Ion channel regulation and function & Nicotinic Acetylcholine Receptors Study. The author has an h-index of 27, co-authored 52 publications.
Papers by this author
worksEfficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant
2013 · European Neuropsychopharmacology · 42 citations
Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy
2015 · The World Journal of Biological Psychiatry · 31 citations
https://doi.org/10.3109/15622975.2014.989261
Safety and Tolerability of Dexmecamylamine (TC-5214) Adjunct to Ongoing Antidepressant Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy
2014 · Journal of Clinical Psychopharmacology · 10 citations
https://doi.org/10.1097/jcp.0000000000000269
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat